These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35534674)

  • 21. HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis.
    Li W; Wang J; Lin H; Shen G
    Medicine (Baltimore); 2020 Dec; 99(52):e23929. PubMed ID: 33350798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.
    Man CB; Kwan P; Baum L; Yu E; Lau KM; Cheng AS; Ng MH
    Epilepsia; 2007 May; 48(5):1015-8. PubMed ID: 17509004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of adverse reactions to antiepileptic drugs.
    Fricke-Galindo I; Jung-Cook H; LLerena A; López-López M
    Neurologia (Engl Ed); 2018 Apr; 33(3):165-176. PubMed ID: 25976948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
    Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH;
    Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.
    Shi YW; Min FL; Liu XR; Zan LX; Gao MM; Yu MJ; Liao WP
    Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):42-6. PubMed ID: 21306565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics of cutaneous adverse drug reactions.
    Aihara M
    J Dermatol; 2011 Mar; 38(3):246-54. PubMed ID: 21342226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic susceptibility to the cross-reactivity of aromatic antiepileptic drugs-induced cutaneous adverse reactions.
    Wang W; Hu FY; Wu XT; An DM; Yan B; Zhou D
    Epilepsy Res; 2014 Aug; 108(6):1041-5. PubMed ID: 24856347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of HLA genetic variants with carbamazepine-induced cutaneous adverse drug reactions: An updated meta-analysis.
    Biswas M; Ershadian M; Shobana J; Nguyen AH; Sukasem C
    Clin Transl Sci; 2022 Aug; 15(8):1887-1905. PubMed ID: 35599240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics of antiepileptic drug-induced hypersensitivity.
    Bloch KM; Sills GJ; Pirmohamed M; Alfirevic A
    Pharmacogenomics; 2014 Apr; 15(6):857-68. PubMed ID: 24897291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
    Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
    Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Chang WC; Hung SI; Carleton BC; Chung WH
    Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):723-734. PubMed ID: 32510242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.
    McCormack M; Urban TJ; Shianna KV; Walley N; Pandolfo M; Depondt C; Chaila E; O'Conner GD; Kasperavičiūtė D; Radtke RA; Heinzen EL; Sisodiya SM; Delanty N; Cavalleri GL
    Pharmacogenomics; 2012 Mar; 13(4):399-405. PubMed ID: 22379998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.
    Ikeda H; Takahashi Y; Yamazaki E; Fujiwara T; Kaniwa N; Saito Y; Aihara M; Kashiwagi M; Muramatsu M
    Epilepsia; 2010 Feb; 51(2):297-300. PubMed ID: 19694795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study.
    Kim JY; Lee J; Ko YJ; Shin JY; Jung SY; Choi NK; Park BJ
    PLoS One; 2013; 8(12):e83849. PubMed ID: 24391836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients.
    Kazeem GR; Cox C; Aponte J; Messenheimer J; Brazell C; Nelsen AC; Nelson MR; Foot E
    Pharmacogenet Genomics; 2009 Sep; 19(9):661-5. PubMed ID: 19668019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
    Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
    Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy.
    Hu FY; Wang W; Ren JC; An DM; Chen JN; Zhou D
    Epilepsy Res; 2016 Aug; 124():12-5. PubMed ID: 27162008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review.
    Kaniwa N; Saito Y
    Ther Adv Drug Saf; 2013 Dec; 4(6):246-53. PubMed ID: 25114785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.
    Cheung YK; Cheng SH; Chan EJ; Lo SV; Ng MH; Kwan P
    Epilepsia; 2013 Jul; 54(7):1307-14. PubMed ID: 23692434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.